DK0630230T3 - Farmaceutiske inhaleringspræparater - Google Patents

Farmaceutiske inhaleringspræparater

Info

Publication number
DK0630230T3
DK0630230T3 DK93906668.4T DK93906668T DK0630230T3 DK 0630230 T3 DK0630230 T3 DK 0630230T3 DK 93906668 T DK93906668 T DK 93906668T DK 0630230 T3 DK0630230 T3 DK 0630230T3
Authority
DK
Denmark
Prior art keywords
pct
composition
sec
medicament
range
Prior art date
Application number
DK93906668.4T
Other languages
Danish (da)
English (en)
Inventor
Lewis James Baskeyfield
Graham Frederick Jay
Paul Wright
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929205183A external-priority patent/GB9205183D0/en
Priority claimed from GB929205738A external-priority patent/GB9205738D0/en
Priority claimed from GB929205739A external-priority patent/GB9205739D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Application granted granted Critical
Publication of DK0630230T3 publication Critical patent/DK0630230T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK93906668.4T 1992-03-10 1993-03-10 Farmaceutiske inhaleringspræparater DK0630230T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929205183A GB9205183D0 (en) 1992-03-10 1992-03-10 Formulation
GB929205738A GB9205738D0 (en) 1992-03-17 1992-03-17 Formulations
GB929205739A GB9205739D0 (en) 1992-03-17 1992-03-17 Formulations

Publications (1)

Publication Number Publication Date
DK0630230T3 true DK0630230T3 (da) 1997-06-02

Family

ID=27266086

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93906668.4T DK0630230T3 (da) 1992-03-10 1993-03-10 Farmaceutiske inhaleringspræparater

Country Status (12)

Country Link
US (1) US5607662A (de)
EP (1) EP0630230B1 (de)
JP (1) JP2736168B2 (de)
AT (1) ATE145819T1 (de)
CA (1) CA2131285C (de)
DE (1) DE69306379T2 (de)
DK (1) DK0630230T3 (de)
ES (1) ES2099428T3 (de)
FI (1) FI110162B (de)
GR (1) GR3022527T3 (de)
NO (1) NO307203B1 (de)
WO (1) WO1993017663A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US6413496B1 (en) 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
US6192882B1 (en) * 1997-02-24 2001-02-27 Aradigm Corporation Formulation and devices for monitoring the efficacy of the delivery of aerosols
US6349719B2 (en) 1997-02-24 2002-02-26 Aradigm Corporation Formulation and devices for monitoring the efficacy of the delivery of aerosols
US5891420A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation
US6129905A (en) * 1997-04-21 2000-10-10 Aeropharm Technology, Inc. Aerosol formulations containing a sugar as a dispersant
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US6197280B1 (en) 1997-09-09 2001-03-06 Bioglan Laboratories Limited Pharmaceutical compositions and devices for their administration
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
WO1999027911A1 (fr) * 1997-12-03 1999-06-10 Fujisawa Pharmaceutical Co., Ltd. Medicament en pastilles souples et procede de fabrication
US6458338B1 (en) 1998-09-22 2002-10-01 Aeropharm Technology Incorporated Amino acid stabilized medicinal aerosol formulations
WO2001026630A1 (fr) * 1999-10-12 2001-04-19 Kaken Pharmaceutical Co., Ltd. Preparations pour inhalation en poudre et leur procede de production
GB9928311D0 (en) * 1999-11-30 2000-01-26 Novartis Ag Organic compounds
GB0010709D0 (en) * 2000-05-03 2000-06-28 Vectura Ltd Powders for use a in dry powder inhaler
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
JP2006087815A (ja) * 2004-09-27 2006-04-06 Canon Inc 噴霧方法および該方法に基づく噴霧装置
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
PL2211896T3 (pl) 2007-11-13 2018-07-31 Meritage Pharma Inc Kompozycje do leczenia zapalenia przewodu pokarmowego
US20090143343A1 (en) * 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
CA2765033C (en) * 2009-06-12 2020-07-14 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
RU2770039C2 (ru) * 2017-03-07 2022-04-14 Филип Моррис Продактс С.А. Вдыхаемые составы на основе никотина и способы их получения и применения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201685B (en) * 1987-04-23 1990-12-28 Chinoin Gyogyszer Es Vegyeszet For producing pharmaceutical compositions for inhalation and compositions for scenting air containing volatile active component in cyclodextrine inclusion, and air-scenting composition
GB8820398D0 (en) * 1988-08-27 1988-09-28 Fisons Plc Pharmaceutical formulation
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers

Also Published As

Publication number Publication date
JP2736168B2 (ja) 1998-04-02
EP0630230B1 (de) 1996-12-04
CA2131285A1 (en) 1993-09-16
NO943241D0 (no) 1994-09-01
GR3022527T3 (en) 1997-05-31
WO1993017663A1 (en) 1993-09-16
NO943241L (no) 1994-09-01
US5607662A (en) 1997-03-04
NO307203B1 (no) 2000-02-28
JPH07504432A (ja) 1995-05-18
EP0630230A1 (de) 1994-12-28
DE69306379T2 (de) 1997-06-12
ATE145819T1 (de) 1996-12-15
ES2099428T3 (es) 1997-05-16
FI944123A0 (fi) 1994-09-08
DE69306379D1 (de) 1997-01-16
FI110162B (fi) 2002-12-13
CA2131285C (en) 2004-06-29
FI944123A (fi) 1994-09-08

Similar Documents

Publication Publication Date Title
DK0630230T3 (da) Farmaceutiske inhaleringspræparater
DE69518334D1 (de) Pharmazeutische aerosol welche mindestens ein zucker enthält
DE69532031D1 (de) Schilddrüsenhormone enthaltende mittel
AU1358695A (en) Nasal administration
HUP9802828A2 (hu) Belélegezhető vivőanyag szabályozott hatóanyag-leadású gyógyszerkészítményekhez
EE03221B1 (et) Inhaleeritavad ravimpreparaadid, nende valmistamise protsess ja inhalaator nende kasutamiseks
MY115688A (en) Pharmaceutical composition for administration by inhalation
ATE113203T1 (de) Darreichnungsform zur verabreichnung eines antiparkinsonsmittel.
RU98111594A (ru) Фармацевтические композиции, включающие флурбипрофен
RU94040387A (ru) Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака
DE69132688D1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
JPH072654A (ja) 吸入によるタウリン投与装置
CA2240717A1 (en) Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
DE69429964D1 (de) Feste, therapeutische oder hygienische, mucoadhäsive Zusammensetzung zur Verabreichung durch Auftragen auf der Mund-schleimhaut oder der Nasen-schleimhaut
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
MY124465A (en) Reduction of infarct volume using citicoline
AU1458495A (en) Application of riluzole in the treatment of mitochondrial diseases
EP0397211A3 (de) Perkutane Verabreichung von 3'-Azido-3'-Deoxythymidin
RU94016196A (ru) Способ лечения больных брюшным тифом
Guleria et al. Double-blind, crossover comparison of carbuterol and salbutamol
KR910005856A (ko) 호흡기 질환 치료용 제약 조성물
RU94025799A (ru) Способ лечения идиопатического дерматомиозита